TIM-3 expression in breast cancer

Tumor-infiltrating lymphocytes (TILs) are predominantly present in breast cancer patients with estrogen receptor negative tumors, among whom increasing levels correlate with favorable outcomes. Nevertheless, currently available immune checkpoint inhibitors appear to benefit only a small number of wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Burugu, Samantha, Gao, Dongxia, Leung, Samuel, Chia, Stephen K., Nielsen, Torsten O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205019/
https://www.ncbi.nlm.nih.gov/pubmed/30377566
http://dx.doi.org/10.1080/2162402X.2018.1502128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205019/
https://www.ncbi.nlm.nih.gov/pubmed/30377566
http://dx.doi.org/10.1080/2162402X.2018.1502128

Ejemplares similares